Sai Parenterals’ Rs 409 crore IPO is set for a flat debut with a 0% grey market premium, reflecting subdued investor sentiment and weak retail subscription. Despite a diversified pharma business and expansion plans, aggressive valuations at over 70 times P/E appear to have deterred individual investors, though institutional participation helped the issue scrape through.
Source :- Markets-Economic Times Read More
